Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. (새로운 창 열기)

Evans WE, Relling MV, Rodman JH, Crom WR, Boyett JM, Pui CH

Source‎: N Engl J Med 1998;338(8):499-505.

Indexed‎: PubMed 9468466

DOI‎: 10.1056/NEJM199802193380803

https://www.ncbi.nlm.nih.gov/pubmed/9468466 (새로운 창 열기)

Childhood cancer and the Jehovah's Witness faith. (새로운 창 열기)

Frankel LS, Damme CJ, Eys JV.

Source‎: Pediatrics 1977;60(6):916-21.

Indexed‎: PubMed 600607

https://www.ncbi.nlm.nih.gov/pubmed/600607 (새로운 창 열기)

Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma. (새로운 창 열기)

Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK

Source‎: J Clin Oncol 2004;22(24):4888-92.

Indexed‎: PubMed 15611504

DOI‎: 10.1200/JCO.2004.02.101

https://www.ncbi.nlm.nih.gov/pubmed/15611504 (새로운 창 열기)

Assessment of arsenic trioxide and all-trans retinoic acid for the treatment of pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group AAML1331 Trial. (새로운 창 열기)

Kutny MA, Alonzo TA, Abla O, Rajpurkar M, Gerbing RB, Wang YC, Hirsch BA, Raimondi S, Kahwash S, Hardy KK, Hardy S, Meshinchi S, Gamis AS, Kolb EA, Feusner JH, Gregory J Jr

Source‎: JAMA Oncol 2022;8(1):79-87. 

Indexed‎: PubMed 34762093

DOI‎: 10.1001/jamaoncol.2021.5206

https://pubmed.ncbi.nlm.nih.gov/34762093/ (새로운 창 열기)

Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia. (새로운 창 열기)

Lou Y, Qian W, Meng H, Mai W, Tong H, Tong Y, Huang J, Jin J.

Source‎: Hematol Oncol 2014;32(1):40-6.

Indexed‎: PubMed 23963734

DOI‎: 10.1002/hon.2076

https://www.ncbi.nlm.nih.gov/pubmed/23963734 (새로운 창 열기)

Acute leukemia in Jehovah's Witnesses: a challenge for hematologists. (새로운 창 열기)

Mazza P, Palazzo G, Amurri B, Cervellera M, Rizzo C, Maggi A

Source‎: Haematologica 2000;85(11):1221-2.

Indexed‎: PubMed 11064477

https://www.ncbi.nlm.nih.gov/pubmed/11064477 (새로운 창 열기)

Autologous and allogeneic stem cell transplant in Jehovah's Witnesses: a single-center experience on 22 patients. (새로운 창 열기)

Mazza P, Palazzo G, Minoia C, Amurri B, Pisapia G

Source‎: Bone Marrow Transplant 2016;51(7):1002-3.

Indexed‎: PubMed 26950381

DOI‎: 10.1038/bmt.2016.29

https://www.ncbi.nlm.nih.gov/pubmed/26950381 (새로운 창 열기)

Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. (새로운 창 열기)

Mazza P, Prudenzano A, Amurri B, Palazzo G, Pisapia G, Stani L, Pricolo G.

Source‎: Bone Marrow Transplant 2003;32(4):433-6.

Indexed‎: PubMed 12900781

DOI‎: 10.1038/sj.bmt.1704179

https://www.ncbi.nlm.nih.gov/pubmed/12900781 (새로운 창 열기)

Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. (새로운 창 열기)

Ruiz-Argüelles GJ, Morales-Toquero A, López-Martínez B, Tarín-Arzaga LD, Manzano C.

Source‎: Bone Marrow Transplant 2005;36(8):715-20.

Indexed‎: PubMed 16113672

DOI‎: 10.1038/sj.bmt.1705126

https://www.ncbi.nlm.nih.gov/pubmed/16113672 (새로운 창 열기)

Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia. (새로운 창 열기)

Zwaan CM, Kaspers GJ

Source‎: Br J Haematol 2004;127(3):264-79.

Indexed‎: PubMed 15491285

DOI‎: 10.1111/j.1365-2141.2004.05167.x

https://www.ncbi.nlm.nih.gov/pubmed/15491285 (새로운 창 열기)

Tratamiento de la leucemia aguda linfoblástica con poliquimioterapia sin hemoderivados en niños Testigos de Jehová​. [Treatment of acute lymphoblastic leukemia using combination chemotherapy without blood-derived products in Jehovah's Witness children. (새로운 창 열기)

​Tenorio-Guajardo G, Ferrer-Argote VE, Glender-Díaz W, Collazo-Jaloma J

Source‎: Rev Med Hosp Gen Mex 2009;72(1):16-9.

Indexed‎: ISSN 0185-1063

https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=21009 (새로운 창 열기)